Orchid Ventures Inc.
Orchid Ventures is a cannabis innovation company with three primary business arms. Orchid Essentials is a cannabis brand with products sold in over 150 dispensaries in California and Oregon and is also a licensing platform for other manufacturers to license the brand in other states and countries. PurTec Delivery Systems is the first vaporizer manufacturer to feature products that are all emissions tested at AFNOR standards making them the highest tested cannabis vaporizers on the market. CELLg8® Sciences is another subsidiary that owns the exclusive license for CELLg8® within the global cannabis market. CELLg8® is a clinically tested and published liposomal technology that is all natural and provides exponentially greater absorption of cannabinoids and other active vitamins, nutrients and herbs. CELLg8® has also had published a clinical study on absorption and a CBD Safety study both of which have been published in the American Journal of Endocannabinoid Medicine.
The Issuer’s mission is to create the highest standards in the cannabis industry and be committed to safety, efficacy, and quality. The issuer provides brand support, hardware and delivery systems, and scientifically proven bioavailability technologies to the cannabis, CBD, and nutraceutical industries.
Orchid Ventures Inc. (ORCD)
le 6 janvier/January
Effective immediately, Orchid Ventures Inc. is suspended pursuant to CSE Policy 3. The suspension is considered a Regulatory Halt as defined in National Instrument 23-101 Trading Rules. A cease trade order has been issued by the Ontario Securities Commission and the British Columbia Securities Commission.
For more information about Cease Trade Orders, visit the Canadian Securities Administrators Cease Trade Order database at www.securities-administrators.ca